Bile Duct Cancer (Cholangiocarcinoma)
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the liver or outside the liver.
- What is Bile Duct Cancer?
- What are the Causes & Risk Factors for Bile Duct Cancer?
- What are the Signs & Symptoms of Bile Duct Cancer?
- How Do You Diagnose Bile Duct Cancer?
- What are the Stages of Bile Duct Cancer?
- What is the Treatment & Prognosis of Bile Duct Cancer?
- Support Groups
- Frequently Asked Questions
- Glossary
- Latest Publications
Brand Names and Generic Names of Drugs for Treatment of Bile Duct Cancer
Mitomycin
Mitomycin is a chemotherapy agent, prescribed for adenocarcinoma (cancer of the stomach or pancreas) either alone or with other medications.
Brand Names :
Almito® [Vial] | Mitocin® [Vial] | Mitocin® [Vial] | Mitodus® [Vial] | Mitodus® [Vial] | Mitomycin-C® [Vial] | Mitomycin-C® [Vial] | Mitonco® [Vial] | Mitonco® [Vial] | Oncocin® [Vial]
More ...
Pemigatinib
Pemigatinib is an anticancer agent indicated for the treatment of bile duct cancer or cholangiocarcinoma.
Sorafenib
Sorafenib is a kinase inhibitor, prescribed for renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer).
Advertisement
